Meditell Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-05-2024
- Paid Up Capital ₹ 10.00 K
as on 24-05-2024
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -26.26%
(FY 2022)
- Profit -439.13%
(FY 2022)
- Ebitda -319.57%
(FY 2022)
- Net Worth -58.46%
(FY 2022)
- Total Assets 33.89%
(FY 2022)
About Meditell Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Dinesh Khandelwal and Kartik Khandelwal serve as directors at the Company.
- CIN/LLPIN
U24239MH2019PTC329741
- Company No.
329741
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Meditell Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Khandelwal  | Director | 26-Aug-2019 | Current |
| Kartik Khandelwal | Director | 26-Aug-2019 | Current |
Financial Performance of Meditell Pharmaceuticals.
Meditell Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.26% decrease. The company also saw a substantial fall in profitability, with a 439.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 58.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meditell Pharmaceuticals?
Unlock access to Meditell Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Meditell Pharmaceuticals?
Unlock and access historical data on people associated with Meditell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meditell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditell Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
